ANNUAL REPORT 2002

 

BIOPURE CORPORATION

TABLE OF CONTENTS:  




Page 7 of 20      < Previous     Next >  


Form 10-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-K

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended October 31, 2002

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____ to _____

Commission File Number 001-15167

BIOPURE CORPORATION
(Exact name of Registrant as specified in its charter)

Delaware
(State or other jurisdiction of incorporation or organization)
04-2836871
(I.R.S. Employer Identification No.)

 

11 Hurley Street, Cambridge, MA
(Address of principal executive offices)
02141
(Zip Code)

 

Registrant's telephone number, including area code: (617) 234-6500

 

Securities registered pursuant to Section 12(b) of the Act:
NONE

 

Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $0.01 par value per share
Preferred Stock Purchase Rights
(Title of Class)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
YesNo


Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.

Indicate by check mark whether the registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2).
YesNo


Based on assumptions relating to the privately held non-voting Class B Common Stock, the aggregate market value of the voting and non-voting common equity held by nonaffiliates of the registrant on April 30, 2002 was $327,418,870.

The number of shares outstanding of the registrant's Class A Common Stock was 30,875,563 on January 17, 2003; the number of shares of the Class B Common Stock as of such date was 117.7.

Documents Incorporated By Reference
Location in Form 10-K

 

Incorporated Document
Part III

 

Specifically identified portions of the registrant's definitive proxy statement to be filed in connection with the registrant's Annual Meeting to be held on April 2, 2003.





Page 7 of 20      < Previous     Next >